Open AccessOral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure—a meta-analysis of randomized controlled trials
Author(s) -
Matthew E. Falagas,
Konstantinos N. Fragoulis,
Ioannis A. Bliziotis
Publication year - 2006
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfl235
Subject(s) - medicine , staphylococcus aureus , meta analysis , carriage , randomized controlled trial , antibacterial agent , hemodialysis , dialysis , antibiotics , methicillin resistant staphylococcus aureus , intensive care medicine , surgery , microbiology and biotechnology , bacteria , pathology , genetics , biology
Rifampin has been studied as prophylaxis against Staphylococcus aureus-related infections in patients on dialysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom